ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intravenous Treatment Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-17U12048
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Intravenous Treatment Market Research Report 2022
BUY CHAPTERS

Global Intravenous Treatment Market Research Report 2024

Code: QYRE-Auto-17U12048
Report
May 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)

Intravenous Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Intravenous Treatment Market

Intravenous Treatment Market

The global Intravenous Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intravenous Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Treatment.

Report Scope

The Intravenous Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Intravenous Treatment Market Report

Report Metric Details
Report Name Intravenous Treatment Market
CAGR 5%
Segment by Type
  • Peripheral Parenteral Nutrition
  • Total Parenteral Nutrition
Segment by Application
  • Hospitals and Clinics
  • Outpatient clinic
  • Home Care
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ICU Medical Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo), Grifols S.A. (Spain)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intravenous Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intravenous Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Intravenous Treatment Market report?

Ans: The main players in the Intravenous Treatment Market are ICU Medical Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo), Grifols S.A. (Spain)

What are the Application segmentation covered in the Intravenous Treatment Market report?

Ans: The Applications covered in the Intravenous Treatment Market report are Hospitals and Clinics, Outpatient clinic, Home Care

What are the Type segmentation covered in the Intravenous Treatment Market report?

Ans: The Types covered in the Intravenous Treatment Market report are Peripheral Parenteral Nutrition, Total Parenteral Nutrition

1 Intravenous Treatment Market Overview
1.1 Product Overview and Scope of Intravenous Treatment
1.2 Intravenous Treatment Segment by Type
1.2.1 Global Intravenous Treatment Market Value Comparison by Type (2024-2030)
1.2.2 Peripheral Parenteral Nutrition
1.2.3 Total Parenteral Nutrition
1.3 Intravenous Treatment Segment by Application
1.3.1 Global Intravenous Treatment Market Value by Application: (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Outpatient clinic
1.3.4 Home Care
1.4 Global Intravenous Treatment Market Size Estimates and Forecasts
1.4.1 Global Intravenous Treatment Revenue 2019-2030
1.4.2 Global Intravenous Treatment Sales 2019-2030
1.4.3 Global Intravenous Treatment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intravenous Treatment Market Competition by Manufacturers
2.1 Global Intravenous Treatment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intravenous Treatment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intravenous Treatment Average Price by Manufacturers (2019-2024)
2.4 Global Intravenous Treatment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Treatment, Product Type & Application
2.7 Intravenous Treatment Market Competitive Situation and Trends
2.7.1 Intravenous Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous Treatment Players Market Share by Revenue
2.7.3 Global Intravenous Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Treatment Retrospective Market Scenario by Region
3.1 Global Intravenous Treatment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intravenous Treatment Global Intravenous Treatment Sales by Region: 2019-2030
3.2.1 Global Intravenous Treatment Sales by Region: 2019-2024
3.2.2 Global Intravenous Treatment Sales by Region: 2025-2030
3.3 Global Intravenous Treatment Global Intravenous Treatment Revenue by Region: 2019-2030
3.3.1 Global Intravenous Treatment Revenue by Region: 2019-2024
3.3.2 Global Intravenous Treatment Revenue by Region: 2025-2030
3.4 North America Intravenous Treatment Market Facts & Figures by Country
3.4.1 North America Intravenous Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intravenous Treatment Sales by Country (2019-2030)
3.4.3 North America Intravenous Treatment Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravenous Treatment Market Facts & Figures by Country
3.5.1 Europe Intravenous Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intravenous Treatment Sales by Country (2019-2030)
3.5.3 Europe Intravenous Treatment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intravenous Treatment Sales by Country (2019-2030)
3.6.3 Asia Pacific Intravenous Treatment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intravenous Treatment Market Facts & Figures by Country
3.7.1 Latin America Intravenous Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intravenous Treatment Sales by Country (2019-2030)
3.7.3 Latin America Intravenous Treatment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intravenous Treatment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intravenous Treatment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Treatment Sales by Type (2019-2030)
4.1.1 Global Intravenous Treatment Sales by Type (2019-2024)
4.1.2 Global Intravenous Treatment Sales by Type (2025-2030)
4.1.3 Global Intravenous Treatment Sales Market Share by Type (2019-2030)
4.2 Global Intravenous Treatment Revenue by Type (2019-2030)
4.2.1 Global Intravenous Treatment Revenue by Type (2019-2024)
4.2.2 Global Intravenous Treatment Revenue by Type (2025-2030)
4.2.3 Global Intravenous Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Intravenous Treatment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intravenous Treatment Sales by Application (2019-2030)
5.1.1 Global Intravenous Treatment Sales by Application (2019-2024)
5.1.2 Global Intravenous Treatment Sales by Application (2025-2030)
5.1.3 Global Intravenous Treatment Sales Market Share by Application (2019-2030)
5.2 Global Intravenous Treatment Revenue by Application (2019-2030)
5.2.1 Global Intravenous Treatment Revenue by Application (2019-2024)
5.2.2 Global Intravenous Treatment Revenue by Application (2025-2030)
5.2.3 Global Intravenous Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Intravenous Treatment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ICU Medical Inc. (U.S.)
6.1.1 ICU Medical Inc. (U.S.) Corporation Information
6.1.2 ICU Medical Inc. (U.S.) Description and Business Overview
6.1.3 ICU Medical Inc. (U.S.) Intravenous Treatment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ICU Medical Inc. (U.S.) Intravenous Treatment Product Portfolio
6.1.5 ICU Medical Inc. (U.S.) Recent Developments/Updates
6.2 B. Braun Melsungen AG (Germany)
6.2.1 B. Braun Melsungen AG (Germany) Corporation Information
6.2.2 B. Braun Melsungen AG (Germany) Description and Business Overview
6.2.3 B. Braun Melsungen AG (Germany) Intravenous Treatment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 B. Braun Melsungen AG (Germany) Intravenous Treatment Product Portfolio
6.2.5 B. Braun Melsungen AG (Germany) Recent Developments/Updates
6.3 Fresenius Kabi AG (Germany)
6.3.1 Fresenius Kabi AG (Germany) Corporation Information
6.3.2 Fresenius Kabi AG (Germany) Description and Business Overview
6.3.3 Fresenius Kabi AG (Germany) Intravenous Treatment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fresenius Kabi AG (Germany) Intravenous Treatment Product Portfolio
6.3.5 Fresenius Kabi AG (Germany) Recent Developments/Updates
6.4 Baxter (U.S.)
6.4.1 Baxter (U.S.) Corporation Information
6.4.2 Baxter (U.S.) Description and Business Overview
6.4.3 Baxter (U.S.) Intravenous Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Baxter (U.S.) Intravenous Treatment Product Portfolio
6.4.5 Baxter (U.S.) Recent Developments/Updates
6.5 Amanta Healthcare (India)
6.5.1 Amanta Healthcare (India) Corporation Information
6.5.2 Amanta Healthcare (India) Description and Business Overview
6.5.3 Amanta Healthcare (India) Intravenous Treatment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amanta Healthcare (India) Intravenous Treatment Product Portfolio
6.5.5 Amanta Healthcare (India) Recent Developments/Updates
6.6 Terumo Medical Corporation (Tokyo)
6.6.1 Terumo Medical Corporation (Tokyo) Corporation Information
6.6.2 Terumo Medical Corporation (Tokyo) Description and Business Overview
6.6.3 Terumo Medical Corporation (Tokyo) Intravenous Treatment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Terumo Medical Corporation (Tokyo) Intravenous Treatment Product Portfolio
6.6.5 Terumo Medical Corporation (Tokyo) Recent Developments/Updates
6.7 Grifols S.A. (Spain)
6.6.1 Grifols S.A. (Spain) Corporation Information
6.6.2 Grifols S.A. (Spain) Description and Business Overview
6.6.3 Grifols S.A. (Spain) Intravenous Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Grifols S.A. (Spain) Intravenous Treatment Product Portfolio
6.7.5 Grifols S.A. (Spain) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Treatment Industry Chain Analysis
7.2 Intravenous Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Treatment Production Mode & Process
7.4 Intravenous Treatment Sales and Marketing
7.4.1 Intravenous Treatment Sales Channels
7.4.2 Intravenous Treatment Distributors
7.5 Intravenous Treatment Customers
8 Intravenous Treatment Market Dynamics
8.1 Intravenous Treatment Industry Trends
8.2 Intravenous Treatment Market Drivers
8.3 Intravenous Treatment Market Challenges
8.4 Intravenous Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)
List of Tables
    Table 1. Global Intravenous Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Intravenous Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Intravenous Treatment Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Intravenous Treatment Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Intravenous Treatment Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Intravenous Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Intravenous Treatment Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Intravenous Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Intravenous Treatment, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Intravenous Treatment, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Intravenous Treatment, Product Type & Application
    Table 12. Global Key Manufacturers of Intravenous Treatment, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Intravenous Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Treatment as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Intravenous Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Intravenous Treatment Sales by Region (2019-2024) & (K Units)
    Table 18. Global Intravenous Treatment Sales Market Share by Region (2019-2024)
    Table 19. Global Intravenous Treatment Sales by Region (2025-2030) & (K Units)
    Table 20. Global Intravenous Treatment Sales Market Share by Region (2025-2030)
    Table 21. Global Intravenous Treatment Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Intravenous Treatment Revenue Market Share by Region (2019-2024)
    Table 23. Global Intravenous Treatment Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Intravenous Treatment Revenue Market Share by Region (2025-2030)
    Table 25. North America Intravenous Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Intravenous Treatment Sales by Country (2019-2024) & (K Units)
    Table 27. North America Intravenous Treatment Sales by Country (2025-2030) & (K Units)
    Table 28. North America Intravenous Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Intravenous Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Intravenous Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Intravenous Treatment Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Intravenous Treatment Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Intravenous Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Intravenous Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Intravenous Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Intravenous Treatment Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Intravenous Treatment Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Intravenous Treatment Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Intravenous Treatment Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Intravenous Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Intravenous Treatment Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Intravenous Treatment Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Intravenous Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Intravenous Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Intravenous Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Intravenous Treatment Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Intravenous Treatment Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Intravenous Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Intravenous Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Intravenous Treatment Sales (K Units) by Type (2019-2024)
    Table 51. Global Intravenous Treatment Sales (K Units) by Type (2025-2030)
    Table 52. Global Intravenous Treatment Sales Market Share by Type (2019-2024)
    Table 53. Global Intravenous Treatment Sales Market Share by Type (2025-2030)
    Table 54. Global Intravenous Treatment Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Intravenous Treatment Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Intravenous Treatment Revenue Market Share by Type (2019-2024)
    Table 57. Global Intravenous Treatment Revenue Market Share by Type (2025-2030)
    Table 58. Global Intravenous Treatment Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Intravenous Treatment Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Intravenous Treatment Sales (K Units) by Application (2019-2024)
    Table 61. Global Intravenous Treatment Sales (K Units) by Application (2025-2030)
    Table 62. Global Intravenous Treatment Sales Market Share by Application (2019-2024)
    Table 63. Global Intravenous Treatment Sales Market Share by Application (2025-2030)
    Table 64. Global Intravenous Treatment Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Intravenous Treatment Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Intravenous Treatment Revenue Market Share by Application (2019-2024)
    Table 67. Global Intravenous Treatment Revenue Market Share by Application (2025-2030)
    Table 68. Global Intravenous Treatment Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Intravenous Treatment Price (US$/Unit) by Application (2025-2030)
    Table 70. ICU Medical Inc. (U.S.) Corporation Information
    Table 71. ICU Medical Inc. (U.S.) Description and Business Overview
    Table 72. ICU Medical Inc. (U.S.) Intravenous Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. ICU Medical Inc. (U.S.) Intravenous Treatment Product
    Table 74. ICU Medical Inc. (U.S.) Recent Developments/Updates
    Table 75. B. Braun Melsungen AG (Germany) Corporation Information
    Table 76. B. Braun Melsungen AG (Germany) Description and Business Overview
    Table 77. B. Braun Melsungen AG (Germany) Intravenous Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. B. Braun Melsungen AG (Germany) Intravenous Treatment Product
    Table 79. B. Braun Melsungen AG (Germany) Recent Developments/Updates
    Table 80. Fresenius Kabi AG (Germany) Corporation Information
    Table 81. Fresenius Kabi AG (Germany) Description and Business Overview
    Table 82. Fresenius Kabi AG (Germany) Intravenous Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Fresenius Kabi AG (Germany) Intravenous Treatment Product
    Table 84. Fresenius Kabi AG (Germany) Recent Developments/Updates
    Table 85. Baxter (U.S.) Corporation Information
    Table 86. Baxter (U.S.) Description and Business Overview
    Table 87. Baxter (U.S.) Intravenous Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Baxter (U.S.) Intravenous Treatment Product
    Table 89. Baxter (U.S.) Recent Developments/Updates
    Table 90. Amanta Healthcare (India) Corporation Information
    Table 91. Amanta Healthcare (India) Description and Business Overview
    Table 92. Amanta Healthcare (India) Intravenous Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Amanta Healthcare (India) Intravenous Treatment Product
    Table 94. Amanta Healthcare (India) Recent Developments/Updates
    Table 95. Terumo Medical Corporation (Tokyo) Corporation Information
    Table 96. Terumo Medical Corporation (Tokyo) Description and Business Overview
    Table 97. Terumo Medical Corporation (Tokyo) Intravenous Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Terumo Medical Corporation (Tokyo) Intravenous Treatment Product
    Table 99. Terumo Medical Corporation (Tokyo) Recent Developments/Updates
    Table 100. Grifols S.A. (Spain) Corporation Information
    Table 101. Grifols S.A. (Spain) Description and Business Overview
    Table 102. Grifols S.A. (Spain) Intravenous Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Grifols S.A. (Spain) Intravenous Treatment Product
    Table 104. Grifols S.A. (Spain) Recent Developments/Updates
    Table 105. Key Raw Materials Lists
    Table 106. Raw Materials Key Suppliers Lists
    Table 107. Intravenous Treatment Distributors List
    Table 108. Intravenous Treatment Customers List
    Table 109. Intravenous Treatment Market Trends
    Table 110. Intravenous Treatment Market Drivers
    Table 111. Intravenous Treatment Market Challenges
    Table 112. Intravenous Treatment Market Restraints
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Intravenous Treatment
    Figure 2. Global Intravenous Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Intravenous Treatment Market Share by Type in 2023 & 2030
    Figure 4. Peripheral Parenteral Nutrition Product Picture
    Figure 5. Total Parenteral Nutrition Product Picture
    Figure 6. Global Intravenous Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Intravenous Treatment Market Share by Application in 2023 & 2030
    Figure 8. Hospitals and Clinics
    Figure 9. Outpatient clinic
    Figure 10. Home Care
    Figure 11. Global Intravenous Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Intravenous Treatment Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Intravenous Treatment Sales (2019-2030) & (K Units)
    Figure 14. Global Intravenous Treatment Average Price (US$/Unit) & (2019-2030)
    Figure 15. Intravenous Treatment Report Years Considered
    Figure 16. Intravenous Treatment Sales Share by Manufacturers in 2023
    Figure 17. Global Intravenous Treatment Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Intravenous Treatment Players: Market Share by Revenue in 2023
    Figure 19. Intravenous Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Intravenous Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Intravenous Treatment Sales Market Share by Country (2019-2030)
    Figure 22. North America Intravenous Treatment Revenue Market Share by Country (2019-2030)
    Figure 23. United States Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Intravenous Treatment Sales Market Share by Country (2019-2030)
    Figure 26. Europe Intravenous Treatment Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Intravenous Treatment Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Intravenous Treatment Revenue Market Share by Region (2019-2030)
    Figure 34. China Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. China Taiwan Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Intravenous Treatment Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Intravenous Treatment Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Intravenous Treatment Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Intravenous Treatment Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. UAE Intravenous Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Intravenous Treatment by Type (2019-2030)
    Figure 54. Global Revenue Market Share of Intravenous Treatment by Type (2019-2030)
    Figure 55. Global Intravenous Treatment Price (US$/Unit) by Type (2019-2030)
    Figure 56. Global Sales Market Share of Intravenous Treatment by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Intravenous Treatment by Application (2019-2030)
    Figure 58. Global Intravenous Treatment Price (US$/Unit) by Application (2019-2030)
    Figure 59. Intravenous Treatment Value Chain
    Figure 60. Intravenous Treatment Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global In Vitro Diagnostics IVD Products and Test Market Research Report 2025
Global Treatment Planning Software Market Research Report 2025
Global Diagnostic Guidewire Market Research Report 2024
Injectable Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Venous Diseases Treatment Market Research Report 2025
Global Treatment Planning Systems Market Research Report 2025
Global IVD Raw Materials Market Insights Forecast to 2030
Global Intracranial Treatment Drug Market Research Report 2025
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Critical Care Therapeutics Market Research Report 2025
Global Still s Disease Treatment Market Research Report 2025
Global Human Interventional Treatment Device Market Research Report 2025
Global Combination Therapy Drug Market Research Report 2025
Global Sepsis Diagnostic Market Research Report 2024
Global Anti Infectives Market Research Report 2025
Pain Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chemical Dosing Units Market Research Report 2025
Global Drugs of Abuse Testing Market Research Report 2024
Global IV Solutions in Containers Market Research Report 2025
Global Intravenous Immunoglobulin IVIg Therapy Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions